Publications by authors named "Spyridon Papiris"

Claim this Profile
C
Complete Blood Cell Count Parameters Predict Mortality in Patients with Hypersensitivity Pneumonitis.
Matthaios Katsaras, Vasilina Sotiropoulou, Effrosyni Manali, Evangelia Fouka, Despoina Papakosta, Spyridon A Papiris

Diagnostics (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERS statement on transition of care in childhood interstitial lung diseases.
Petr Pohunek, Effrosyni Manali, Susanne Vijverberg, Julia Carlens, Felix Chua, Spyridon Papiris

Eur Respir J· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic pulmonary fibrosis.
Theodoros Karampitsakos, Apostolos Galaris, Serafeim Chrysikos, Ourania Papaioannou, Ioannis Vamvakaris, Spyridon Papiris

Respir Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCA3-related interstitial lung disease beyond infancy.
Yang Li, Elias Seidl, Katrin Knoflach, Florian Gothe, Maria Elisabeth Forstner, Spyridon A Papiris

Thorax· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psoriatic Insomnia: A Subjective and Objective Sleep Evaluation.
Katerina Vlami, Kleoniki Pantelidi, Maria Dalamaga, Fani Karagianni, Konstantinos Theodoropoulos, Spyridon Papiris

Acta Derm Venereol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe.
Theodoros Karampitsakos, Paolo Spagnolo, Nesrin Mogulkoc, Wim A Wuyts, Sara Tomassetti, Spyridon Papiris

Respirology· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics.
Andriana I Papaioannou, Evangelia Fouka, Nikolaos Tzanakis, Katerina Antoniou, Konstantinos Samitas, Spyridon Papiris

J Allergy Clin Immunol Pract· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sestrin 2 levels are associated with emphysematous phenotype of COPD.
Leonidas Angelakis, Andriana I Papaioannou, Evgenia Papathanasiou, Argiro Mazioti, Maria Kallieri, Spyridon Papiris

PLoS One· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paucigranulocytic Asthma: Potential Pathogenetic Mechanisms, Clinical Features and Therapeutic Management.
Andriana I Papaioannou, Evangelia Fouka, Polyxeni Ntontsi, Grigoris Stratakos, Spyridon Papiris

J Pers Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis.
Theodoros Karampitsakos, Ourania Papaioannou, Ilias Dimeas, Panagiota Tsiri, Vasilina Sotiropoulou, Spyridon Papiris

ERJ Open Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presenting Features and Clinical Course of Chronic Nitrofurantoin-Induced Lung Toxicity.
Vasilios Tzilas, Antonios Charokopos, Lykourgos Kolilekas, Effrosyni Manali, Spyridon Papiris

Chest· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological characteristics and outcomes from 187 patients with COVID-19 admitted to 6 reference centers in Greece: an observational study during the first wave of the COVID-19 pandemic.
Argyris Tzouvelekis, Karolina Akinosoglou, Theodoros Karampitsakos, Vassiliki Panou, Ioannis Tomos, Spyridon Papiris

Adv Respir Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Device use errors among patients with asthma and COPD and the role of training: a real-life study.
Andriana I Papaioannou, Konstantinos Bartziokas, Georgios Hillas, Evangelia Fouka, Katerina Dimakou, Spyridon Papiris

Postgrad Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis.
Theodoros Karampitsakos, Sebastiano Torrisi, Katerina Antoniou, Effrosyni Manali, Ioanna Korbila, Spyridon Papiris

Respir Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of omalizumab in patients with allergic asthma: A real-life study.
Andriana I Papaioannou, Myrto Mplizou, Konstantinos Porpodis, Evangelia Fouka, Eleftherios Zervas, Spyridon Papiris

Allergy Asthma Proc· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease.
Wim A Wuyts, Marlies Wijsenbeek, Benjamin Bondue, Demosthenes Bouros, Paul Bresser, Spyridon Papiris

Respiration· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutation.
Aurélien Justet, Dymph Klay, Raphaël Porcher, Vincent Cottin, Kais Ahmad, Spyridon Papiris

Eur Respir J· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching between biologics in severe asthma patients. When the first choice is not proven to be the best.
Andriana I Papaioannou, Evangelia Fouka, Despina Papakosta, Spyridon Papiris, Stelios Loukides

Clin Exp Allergy· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Burden and Management of Systemic Sclerosis-Associated Interstitial Lung Disease in 8 European Countries: The BUILDup Delphi Consensus Study.
Jesper Rømhild Davidsen, Jelle Miedema, Wim Wuyts, Maritta Kilpeläinen, Spyridon Papiris

Adv Ther· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous Immunoglobulin for the Treatment of COVID-19: A Promising Tool.
Vasilios Tzilas, Effrosyni Manali, Spyridon Papiris, Demosthenes Bouros

Respiration· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Burden of Progressive Fibrosing Interstitial Lung Disease: A DELPHI Approach.
Wim A Wuyts, Spyridon Papiris, Effrosyni Manali, Maritta Kilpeläinen, Jesper Rømhild Davidsen

Adv Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Greece.
Argyris Tzouvelekis, Theodoros Karampitsakos, Georgia Gomatou, Evangelos Bouros, Vassilios Tzilas, Spyridon Papiris

Pulm Pharmacol Ther· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evAluatIon foR inhalation devices in Greek patients with COPD and asthma: The PAIR study.
Theodoros Karampitsakos, Georgios Hillas, Eleftherios Zervas, Petros Bakakos, Grigorios Stratakos, Spyridon Papiris

Pulm Pharmacol Ther· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sirtuin 1: Endocan and Sestrin 2 in Different Biological Samples in Patients with Asthma. Does Severity Make the Difference?
Zoe Tsilogianni, Jonathan R Baker, Anastasia Papaporfyriou, Andrianna I Papaioannou, Evgenia Papathanasiou, Spyridon Papiris

J Clin Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Existing and emerging treatments for idiopathic pulmonary fibrosis.
Lykourgos Kolilekas, Spyridon Papiris, Demosthenes Bouros

Expert Rev Respir Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis